Clinical Trial: Effect of Probiotics (Bio-Three) in Children's Enterocolitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Postmarketing Study of Probiotics Medication in Childhood Diarrhea

Brief Summary: Probiotic bacteria inhabit the gastrointestinal tracts of healthy individuals and may improve the health status of patients with digestive disease. The first aim of our study will seek to determine if probiotics medication (Bio-Three) inhibit gastrointestinal infection and reduce its inflammatory response in the intestine. The second aim will explore the bacterial count (microbiology) and subsequent immune response in probiotic inhibition of enterocolitis in children. We try to seek to gain an advanced understanding of probiotics versus pathogenic microorganism and host interactions, and mucosal immune responses to probiotics in the intestine.